The antitumor agent cis-Pt(NH 3 ) 2 Cl 2 : distribution studies and dose calculations for  193m Pt and  195m Pt.
D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use*; D001921:Brain / Q000378:metabolism; D005260:Female; D006801:Humans; D007421:Intestine, Small / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism; D009368:Neoplasm Transplantation; D010984:Platinum / Q000378:metabolism / Q000627:therapeutic use*; D011868:Radioisotopes; D012510:Sarcoma 180 / Q000188:drug therapy / Q000378:metabolism; D012886:Skull / Q000378:metabolism; D013154:Spleen / Q000378:metabolism; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000378:metabolism
D000970:Antineoplastic Agents; D011868:Radioisotopes; D010984:Platinum